These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25819147)

  • 1. [Non-invasive assessment of fatty liver].
    Egresi A; Lengyel G; Hagymási K
    Orv Hetil; 2015 Apr; 156(14):543-51. PubMed ID: 25819147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Options for non-invasive assessment of liver fibrosis based on clinical data].
    Egresi A; Lengyel G; Hagymási K
    Orv Hetil; 2015 Jan; 156(2):43-52. PubMed ID: 25563681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
    de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
    Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.
    Thavorn K; Coyle D
    Ont Health Technol Assess Ser; 2015; 15(19):1-58. PubMed ID: 26664666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases.
    Ballestri S; Nascimbeni F; Baldelli E; Marrazzo A; Romagnoli D; Targher G; Lonardo A
    Metabolism; 2017 Jul; 72():57-65. PubMed ID: 28641784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive diagnosis of steatosis and fibrosis.
    Castera L
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):674-9. PubMed ID: 19195629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic steatosis in obese Chinese children.
    Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: Non-alcoholic fatty liver disease.
    Alba LM; Lindor K
    Aliment Pharmacol Ther; 2003 Apr; 17(8):977-86. PubMed ID: 12694079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
    de Lédinghen V; Wong GL; Vergniol J; Chan HL; Hiriart JB; Chan AW; Chermak F; Choi PC; Foucher J; Chan CK; Merrouche W; Chim AM; Le Bail B; Wong VW
    J Gastroenterol Hepatol; 2016 Apr; 31(4):848-55. PubMed ID: 26514665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology and biopsy assessment of non-alcoholic fatty liver disease.
    Straub BK; Schirmacher P
    Dig Dis; 2010; 28(1):197-202. PubMed ID: 20460911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.
    Schwenzer NF; Springer F; Schraml C; Stefan N; Machann J; Schick F
    J Hepatol; 2009 Sep; 51(3):433-45. PubMed ID: 19604596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in noninvasive methods for diagnosing nonalcoholic fatty liver disease.
    Shen FF; Lu LG
    J Dig Dis; 2016 Sep; 17(9):565-571. PubMed ID: 27429213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
    Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
    World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
    Ratziu V; Massard J; Charlotte F; Messous D; Imbert-Bismut F; Bonyhay L; Tahiri M; Munteanu M; Thabut D; Cadranel JF; Le Bail B; de Ledinghen V; Poynard T; ;
    BMC Gastroenterol; 2006 Feb; 6():6. PubMed ID: 16503961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The full spectrum of hepatic steatosis in children.
    Hourigan SK; Torbenson M; Tibesar E; Scheimann AO
    Clin Pediatr (Phila); 2015 Jun; 54(7):635-42. PubMed ID: 25567295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis.
    Yilmaz B; Koklu S; Buyukbayram H; Yalçin K; Korkmaz U; Posul E; Can G; Kurt M
    Afr Health Sci; 2015 Sep; 15(3):714-8. PubMed ID: 26957957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic steatosis and fibrosis: Non-invasive assessment.
    Karanjia RN; Crossey MM; Cox IJ; Fye HK; Njie R; Goldin RD; Taylor-Robinson SD
    World J Gastroenterol; 2016 Dec; 22(45):9880-9897. PubMed ID: 28018096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index and liver stiffness affect accuracy of ultrasonography in detecting steatosis in patients with chronic hepatitis C virus genotype 1 infection.
    Macaluso FS; Maida M; Cammà C; Cabibi D; Alessi N; Cabibbo G; Di Marco V; Craxì A; Petta S
    Clin Gastroenterol Hepatol; 2014 May; 12(5):878-884.e1. PubMed ID: 24112998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.